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Overview
Vitamin D is a secosteroid which is converted into
its active form via 1 α-hydroxylase enzyme. Though
kidney is the classical site for 1 α-hydroxylase activity,
it is also expressed in other tissues such as endothelial
and vascular smooth muscle cells1. Besides, vitamin D
receptor (VDR) is present in more than 30 different
tissues including pancreas, myocardium, lymphocytes,
etc. The widespread distribution of VDR signifies
important role of vitamin D in humans2. While vitamin
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Studies from our center and other parts of India have drawn attention towards wide prevalence of
vitamin D deficiency (VDD) in our country. VDD has been reported in all age groups including
toddlers, school children, pregnant women and their neonates and adult males and females residing
in rural and urban India. We reviewed implications of VDD in our population based on the
preliminary data available from Indian studies on skeletal health. Besides, a brief review is made
on the importance of VDD in various other disorders prevalent in equivalent proportions among
Indians such as type 2 diabetes mellitus (DM), cardiovascular diseases (CVD), immune competence
including relation to tuberculosis, malignancy and osteoarthritis. Data from the West have also
associated VDD with increased prevalence of type 2DM, CVD, autoimmune disorders, tuberculosis,
prostate, breast and colon malignancy and osteoarthritis. Such association has not been studied to
date in our country. Overall results of various studies conducted to date in urban and rural Indians
indicate that widely prevalent VDD is functionally relevant to skeletal health including osteomalacia
and rickets. However, there is a need to explore its association with osteoporosis related fractures
and various other non skeletal disorders linked with VDD.
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D is critical for calcium homeostasis, current studies
also highlight role of vitamin D deficiency (VDD) in
diseases other than the metabolic bone disorders.
Studies from our center and other parts of India have
drawn attention towards wide prevalence of VDD in
Asian Indians when currently proposed cut-off are used
to define vitamin D sufficiency. Although, VDD in
Asian Indians has several potential implications, there
has been no systematic efforts to date directed towards
finding the importance of widespread VDD in our
country. In the present article we would focus on the
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implications of VDD in our population based on the
preliminary data available from Indian studies on
skeletal health. Besides we would briefly review the
world literature related to VDD and several disorders
which are prevalent in equivalent proportions among
Indians such as type 2 diabetes mellitus (DM),
cardiovascular diseases (CVD), immune competence
including relation to tuberculosis, malignancy and
osteoarthritis.
Prevalence of  hypovitaminosis D in India
In the western view, VDD was considered to be
rare in India3. Such belief was based on studies
measuring serum calcium and alkaline phosphatase in
our population3. However, till the year 2000, there was
no systematic study which directly assessed body
vitamin D status of Asian Indians residing in India4. In
2000, we first measured serum 25(OH)D using sensitive
and specific assay in apparently healthy subjects in
Delhi and showed that significant hypovitaminosis D
was present in up to 90 per cent of them4. Subsequently,
series of studies from different parts of our country have
pointed towards widespread VDD in Asian Indians of
all age groups including toddlers, school children,
pregnant women and their neonates and adult males
and females residing in rural or urban areas5-9. Skin
complexion, poor sun exposure, vegetarian food habits
and lack of vitamin D food fortification programme in
the country explain the high prevalence of VDD in India
despite its sunny climate4.
Vitamin D deficiency and skeletal health in Indians
Vitamin D deficiency rickets and osteomalacia are
widely prevalent in our country10-12. On an average 25-
30 cases of clinically overt patients with vitamin D
deficiency related osteomalacia in adolescent and adult
age group are managed in our indoor endocrine services
every year. Most of them have undetectable serum
25(OH) D levels with serum parathyroid hormone
(PTH) values more than four folds above upper limit
of normal. In such a scenario, anticonvulsant and
antituberculous therapy, fluoride excess, prolonged
steroid therapy and bisphosphonates easily precipitate
clinically overt rickets and osteomalacia in our
population. Almost one third of our patients with
osteomalacia have history of anticonvulsant, anti-
tuberculous therapy or steroid use in the immediate
preceding years. Such therapies precipitate
osteomalacia because of induction of vitamin D
synthetic pathway towards inactive products. Because
of these reasons it has been our standard practice to
prescribe calcium and vitamin D supplementation in
all the patients put on steroid, anti-tuberculous or
anticonvulsant therapy, at least in double the
recommended daily allowance.
Besides it is not unusual to find biochemical
osteomalacia in our apparently healthy population on
routine screening. Wide prevalence of clinically overt
osteomalacia/rickets and associated pseudofractures
could be due to VDD related low peak bone mass in
Asian Indians. The beneficial effect of 25(OH) D
supplementation in improving skeletal health would
start from in utero and infancy and continue through
childhood, adolescence and adulthood4-8,11,12.
Newborns and vitamin D deficiency
Pregnant women in India have been shown to have
up to 84 per cent prevalence of VDD which correlated
significantly with serum 25(OH) D status of their
newborn6. Mothers with suboptimal vitamin D status
have offsprings with reduced intrauterine and postnatal
skeletal development13,14. Brooke et al15 first reported
reduced incidence of low birth weight babies in vitamin
D supplemented Asian mothers. Vitamin D and calcium
supplementation of the pregnant mothers is associated
with increased skeletal growth and bone mass in the
offsprings16. Marya et al17 from Rohtak, reported higher
body weight, crown heel length, head circumference
and mid arm circumference in mothers who received
two doses of 60,000 IU of vitamin D3 during third
trimester pregnancy compared to those who did not
receive vitamin D317. Besides Apgar score at birth was
higher in newborns of mothers with adequate calcium
and vitamin D intake than in newborns whose mothers
had inadequate intake18. Mannion et al19 have shown
that each additional microgram of vitamin D, was
associated with an 11 g increase in birth weight. Morley
et al20 showed that gestation length was 0.7 wk shorter
and knee-heel length was 4.3 mm smaller in infants of
mothers with 25(OH) D <11.2 ng/ml at 28-32 wk when
compared to babies whose mothers had higher
concentrations. Thus, VDD manifests with
compromised length from birth itself without any
potential for catch up growth in view of the fact that
VDD continues to afflict even toddlers and school
children in India. Finally, as discussed below it would
manifest in compromised adult height.
School children and vitamin D deficiency
Marwaha et al8 showed lower forearm bone density
and mean serum 25(OH) D levels in school children
from low socio-economic region as compared to
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children from high socio-economic region. Recently,
Shatrugna et al21 from National Institute of Nutrition,
Hyderabad, studied the effect of micronutrient
supplementation in schoolchildren of 6 to 16 yr of age.
After 14 months of supplementation, the increments in
height, weight, whole body bone mineral content, and
bone mineral density (BMD) at neck of the femur were
significantly greater in the supplemented than in the
placebo group. The above studies confirm that the
suboptimal calcium and vitamin D status are important
contributory factors in determining height and bone
health in school children in India.
Adults and vitamin D deficiency
VDD in Asian Indians has been shown to be
associated with higher serum PTH and lower serum
calcium. Such effects would promote bone resorption
and precipitate osteomalacia and osteoporosis in
predisposed individuals. While it is common to see
lower T and Z scores in BMD reports from our country,
there is paucity of population based systematic data
related to prevalence of osteoporosis in adult Indian
population. Rarer are the adequately designed studies
assessing association between serum 25(OH) D and
BMD in Indian population. Shatrugna et al22 studied
prevalence of osteoporosis in 289 middle aged women
from Hyderabad. The prevalence of osteoporosis at the
femoral neck was around 29 per cent. The T scores in
the BMD of Indian women studied at all the skeletal
sites were much lower than the values reported from
the developed countries. BMD showed a decline after
the age of 35 yr at lumbar spine and femoral neck. On
multiple regression analysis, calcium intake of women
appeared as an important determinant of BMD.
However, 25 (OH) D status was not assessed in the
study22.
Several investigators from west have reported
significantly lower hip BMD in subjects with low serum
25(OH)D concentrations23-26. Besides, vitamin D
supplementation led to beneficial effect on hip BMD27,28.
There have been only two studies which have directly
assessed relationship between body vitamin D status
and BMD in apparently healthy Asian Indians. Arya et
al5 observed a positive correlation between serum
25(OH) D concentrations and hip BMD in a cohort of
92 healthy subjects from Lucknow. Recently we also
observed a significant relation between serum 25(OH)
D concentrations and hip BMD but not with lumbar
spine or forearm BMD in an urban Delhi cohort29.
Differential effects of VDD on BMD at various sites
possibly involve factors other than hypovitaminosis D.
In this context we studied genetic variation related to
VDR polymorphism. Among the three VDR single
nucleotide polymorphisms studied (TaqI, FokI and
BsmI), subjects with TaqI-TT genotype had a
significantly higher BMD at the forearm than did
subjects with Tt and tt genotypes29. The finding of
correlation of VDR gene polymorphism with forearm
BMD among Indians is interesting and indicates that
even in a severely hypovitaminotic D population,
variations in BMD at forearm could be explained by
genetic factors.
Overall results of various studies conducted to date
in urban and rural India indicate that widely prevalent
VDD is functionally relevant in view of associated
increase in serum PTH and low BMD. However, there
has been no systematic study which has assessed the
association between osteoporosis related non-trivial
fracture rates and serum 25(OH) D status among
Indians. If such study is being planned it would also be
important to take into consideration variables such as
poor musculoskeletal strength and propensity to fall.
Both these factors have also been reported to contribute
to fractures in hypovitaminosis D state30,31.
Vitamin D deficiency and type 2 diabetes mellitus
Currently the prevalence of type 2 DM is high in
urban as well as rural India32,33 and by 2030, Asians
Indian would bear the maximum burden of the disease
in the world34. Glycaemic control tends to worsen in
winter months and is believed to be because of
concomitant fall in 25(OH) D in this season35,36. Pittas37
has systematically reviewed world literature related to
(i) association between VDD and prevalence/incidence
of type 2 DM in different population, and (ii)
randomized trials assessing role of vitamin D
supplementation on glucose metabolism.
The cross-sectional study involving largest cohort
of non diabetic Americans (n = 6288) reported an
inverse relationship between serum 25(OH)D
concentration and fasting or post glucose load values37,38.
A meta-analysis carried out after combining data from
all studies revealed an odds ratio of 0.54 (95% CI, 0.23-
1.27) for the highest versus lowest 25(OH)D
concentration (25–38 vs. 10-23 ng/ml, respectively)37.
In nine of 13 case-control studies reviewed by the
authors, patients with type 2 diabetes showed a lower
mean 25(OH)D concentrations than the non diabetic
controls37. Association between vitamin D intake and
incidence of type 2 DM was examined in Women’s
Health Study37,39. Subjects with daily vitamin D intake
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>511 IU had lower risk of incidence of DM when
compared to a cohort with daily vitamin D intake of
<159 IU per day (2.7% vs. 5.6%). Pittas et al40 also
examined association between combined vitamin D and
calcium intake and incidence of type 2 DM among
83,806 women in Nurses’ Health Study. After adjusting
for age, BMI, and non dietary covariates, a significant
inverse association was observed between vitamin D
intake and calcium intake on one hand and risk of type
2 DM on the other.
There is a paucity of interventional trials assessing
effect of vitamin D supplementation on glycaemic
control over long term period. Pittas et al41 studied 92
diabetic subjects and reported decrease in fasting plasma
glucose after 3 yr in group receiving daily
supplementation of 700 IU of vitamin D and 500 mg of
calcium citrate. The potential mechanisms of beneficial
effect of vitamin D in type 2 DM include (i) improved
β-cell function via direct effect of vitamin D or by
increase in the intracellular ionized calcium which
therefore would result in enhanced insulin release, (ii)
increased insulin sensitivity related to expression of
insulin receptor or via calcium dependent pathways in
target cells leading to increase in the glucose utilization,
and (iii) inhibition of β-cells apoptosis due to VDR
transcription factor mediated inhibition of cytotoxic
cytogene gene expression37. While there is a possibility
that widespread prevalence of type 2 DM observed in
Asian Indians could be partially related to VDD, there
are no data available among Indian subjects on VDD
and its effect on beta cell function or insulin sensitivity.
Vitamin D deficiency in cardiovascular diseases
Rheumatic heart disease and associated heart failure
are common in India. The estimated prevalence of
coronary heart disease is also high (8-10%) in urban
India42,43. The high prevalence of CVD in renal failure
is linked with lower levels of vitamin D metabolites44.
There is increasing evidence that VDD might be an
important determinant in the pathogenesis of CVD,
hypertension and congestive heart failure44.
Recently, Zittermann et al44 reviewed various
studies reporting association between CVD and VDD
in context of increased prevalence of coronary artery
disease (CAD), vascular calcification and essential
hypertension. Besides, intervention trials assessing role
of vitamin D supplementation in CVD were also
reviewed. Study by Watson et al45 reported inverse
correlation of serum 1,25(OH)2D3 and presence of
coronary artery calcification in subjects with
hypercholesteraemia who are at  high risk for CAD
(Framingham cohort) and also in asymptomatic
individuals from Southway with moderate risk of CAD
when followed up for four years. Circumstantial
evidences also indicated an increase in the risk of CAD
with increasing geographic latitude and associated fall
in serum 25(OH) D. On the contrary, there was a decline
in mortality from CAD for males in the New Mexico
with higher altitudes46. On an average, an increase of
1000 meter in the altitude of residence was associated
with a 28 per cent decrease in mortality rates associated
with CAD46. In addition, several studies also
demonstrated increase in the coronary events and
associated mortality (up to 40%) in winter season when
compared to other seasons44,47. We reported seasonal
variation of serum 25(OH) D levels with almost
undetectable 25(OH) D levels in winter in Indians despite
its sunny climate4. Zitterman et al44 also suggested high
prevalence of CAD in urban population when compared
to the rural population could be due to VDD secondary
to environmental pollution linked block in UV rays.
Agarwal et al48 also reported environmental pollution
and haze related fall in serum 25(OH) D in urban Delhi.
The incidence of hypertension also followed an
inverse relation with serum 25(OH) D49,50 and increased
intake of vitamin D was associated with 9.3 per cent
decrease in systolic blood pressure51. Interventional
studies had also shown up to 40 per cent fall in C-
reactive protein (CRP) and interleukin-6 (inflammatory
markers of CAD) at the end of one year in patients with
CAD put on three monthly injections of 1250 µg
cholecalciferol52. Similar fall in CRP levels were also
observed during short term intervention with daily 12.0
µg vitamin D in patients admitted for short duration in
an intensive care unit53. Besides, McGonigle et al54
found significant improvement in left ventricular
function with 1 α vitamin D3.
The possible reasons for the harmful effect of VDD
on CAD, HT and congestive heart failure (CHF)
reported in various studies could be due to the
combination of the following (i) inhibition of VDR
mediated Gla matrix protein expression which would
result in activation of vascular calcification, (ii)
increased PTH levels and associated myocardial,
valvular and vascular calcification, (iii) activation of
pro-inflammatory cytokines, (iv) suppression of an anti-
inflammatory cytokine IL-10, and (v) stimulation of
renin angiotensin system55-58.
Approximately 30 million subjects (14.1 million
in urban areas, and 15.7 million in rural areas) are likely
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to be affected with CAD in our country42. Interestingly,
CHD also manifests almost a decade earlier in India
when compared to western countries42. Though there
have been a few case reports showing improvement in
ejection fraction following calcium and vitamin D
supplementation in Indian patients with CHF and
hypocalcaemia59,60, there is no systematic study
assessing association of VDD with postpartum
cardiomyopathy, CHF and  CHD.
Vitamin D deficiency and immune system
Vitamin D deficiency and autoimmunity: Most of the
autoimmune disorders are observed in
immunogenetically predisposed individuals when
exposed to adverse environmental agents such as viruses
and altered nutritional factors. The classical example
is increase in the incidence of autoimmune thyroiditis
following iodine supplementation in iodine deficient
population61. Recently, VDD has been implicated as a
triggering factor in autoimmune disorders such as type
1 diabetes mellitus (T1DM), inflammatory bowel
disease (IBD) and multiple sclerosis (MS)62. VDR is
expressed in peripheral blood monocytes, macrophages,
dendritic cells, leukocytes and activated CD4+ and
CD8+ T cells and as a results VDD can have widespread
effects on immune effectors response62-65. 1,25(OH)2 D3
mediating its action through VDR has been reported to
inhibit proliferation of Th1-helper cells and secretion
of cytokines such IL-2 and interferon gamma (INF-γ).
Vitamin D enhances IL-4 response due to its stimulatory
effect on Th2 cells66,67. Therefore, vitamin D modulates
T cell differentiation towards Th2 phenotype and
inhibits Th1 development and could result in
predisposition to various autoimmune disorders.
Epidemiological studies support association between
VDD and seasonal pattern in the onset of TIDM, IBD
and MS68-71. Population based studies had shown that
vitamin D supplementation during early years of life
was associated with decreased frequency of T1DM72,73.
Rickets during first year of life was associated with
increase risk of TIDM74. Further, presence of islet auto-
antibodies in offspring was inversely related to maternal
vitamin D intake during pregnancy75. The higher
prevalence of IBD was also reported form the
geographical regions of North America and Northern
Europe with limited sunshine76,77. Higher incidence of
IBD was reported in Asians migrated to Europe78.
T1DM was considered to be rare in India. However,
studies have indicated that T1DM is the second most
common autoimmune endocrine disease in India with
an annual incidence of 10.5/100,00079,80. Similarly,
contrary to the previous belief about the rarity of IBD
in India, Sood et al81 showed that disease is widely
prevalent in India when careful house-to-house surveys
were carried out in Punjab. Interestingly, it has been
suggested that environmental triggers play a major role
in Indian patients with multiple sclerosis in view of
absence of family history in majority of the patients,
unlike in USA82. VDD could be one such triggering
factor in view of its linkage with MS. Though
autoimmune disorders such as T1DM, MS and IBD are
common in India, there have been no study to date
assessing the role of VDD among Indians in any of the
above disorders.
Vitamin D deficiency and tuberculosis: Tuberculosis is
an important public health problem in India. Role of VDD
in predisposition to tuberculosis has been speculated for
a long time. Cod liver oil was first advocated for the
treatment of tuberculosis in 1770 and was widely used
till the 19th century83,84. Patients with tuberculosis were
also advised treatment at sanatorium where sunshine was
available in plenty. Calciferol was used to treat
tuberculosis in the late 1940s and treatment was
rationalised based on its role in the calcification of
tuberculosis lesions. With the advent of effective
antituberculosis drugs in the mid 1950s, enthusiasm for
treating tuberculosis with vitamin D subsided. However,
it formed the basis of subsequent investigations linking
VDD with pulmonary tuberculosis85-88. Davies89 reported
significantly lower levels of serum 25(OH) D in patients
with untreated tuberculosis in comparison to healthy
controls. In a similar study, Grange et al90 showed that
patients with higher 25(OH) D levels had less extensive
radiographic disease. Douglas et al91 reported a striking
seasonal variation of tuberculosis incidence, with peak
during the summer and nadir in the spring; unlike other
respiratory diseases. Seasonal changes in vitamin D levels
were suggested as the possible cause for the paradoxical
reversed seasonality of tuberculosis90-92.
Vitamin D supplementation in tuberculosis: Recently,
Nursyam et al93 carried out a placebo-controlled
randomized trial of vitamin D supplementation (0.25
mg/day for initial 6 wk) in 67 patients with pulmonary
tuberculosis. All the subjects in the vitamin D
supplemented group and only 76.7 per cent in the
placebo group had sputum conversion. In another
randomized control trial, addition of vitamin D to
standard antitubercular therapy resulted in higher rate
of clinical and radiological improvement94.
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Vitamin D, immune shifts and tuberculosis: Incubation
of macrophages with physiological concentration of 1,
25(OH)2 D (10-9M) led to inhibition of intracellular
growth of Mycobacterium tuberculosis95. In in vitro
studies 1,25-dihydroxycholecalciferol had significant
immunomodulatory effects leading to a shift in cytokine
profile of T-helper (Th1 to Th2) and reduced antigen
presentation96. With the currently available knowledge
it is difficult to explain beneficial effect of vitamin D
supplementation on the basis of shift in the immune
mechanism because vitamin D supplementation would
enhance Th2 cytokine response rather than beneficial
Th1 response. Recently Liu et al97 have shown  that
vitamin D supplementation results in  increased
expression of antimicrobial peptide ‘cathelicidin’ in the
macrophage culture, which could result in killing of
the  intracellular M. tuberculosis. This is a potential
mechanism which could logically explain role of
vitamin D in enhancing innate immunity in patients with
tuberculosis. However, studies related to the shift in
immune responses in vitamin D deficient state have
only been conducted in experimental and in vitro
conditions. There is a paucity of comprehensive and
systematic studies on the impact of vitamin D therapy
in human subjects with tuberculosis in terms of
immunity.
Vitamin D deficiency and malignancy
Schwartz et al98 first provided evidence of
relationship between VDD and cancer by reporting
higher mortality in patients with prostate cancer with
increasing latitudes. Giovannucci et al99 reported 17 per
cent reduction in cancer incidence and 29 per cent
reduction in total mortality for 10 ng/ml increase in
predicted 25(OH) D concentrations. The maximum
beneficial effect was observed for gastrointestinal
cancer. Skinner et al100 reported 41 per cent lower risk
of pancreatic cancer among subjects consuming >600
IU vitamin D daily in comparison to those with <150
IU per day. Similar inverse relation with vitamin D
nutritional status was also reported for colorectal
adenomas, endometrial and breast carcinoma. Besides,
Hartman et al101 reported 18 per cent lower recurrence
of adenomatous polyps in ‘Polyp Prevention Trial’
among subjects on vitamin D supplementation. Various
mechanisms implicated in anticancer effects of vitamin
D involve cell cycle regulation, induction of apoptosis,
cell differentiation, disruption of growth factor mediated
cell survival signals and inhibition of angiogenesis and
cell adhesion102.
Average annual incidence rates of cancer in India
range from 5.0 to 9.1 per 100,000/yr for prostate and
7.2 to 31.3 per 100,000/yr for female breast103. Hebert
et al103 also reported that most of the prostate and breast
carcinoma in India were diagnosed in the late stages in
comparison to the USA where only 15 per cent cases
were diagnosed in the advanced stage. Role of VDD
deficiency in wide prevalence of advanced carcinoma
of the breast and prostate in India is not known.
Interestingly, vitamin D and its analogues inhibit the
invasiveness and angiogenesis of several cell types in
in vitro studies104,105. There is a need to perform studies
relating VDD and advanced stage of malignancy
observed in India.
Vitamin D deficiency and osteoarthritis
Osteoarthritis of the knee and hip are common in
India. Community surveys carried out in adult
population in rural Pune and rural and urban subjects
in Chandigarh revealed up to 29 and 33 per cent
prevalence of osteoarthritis of the knee joint in these
regions, respectively106,107. VDD had also been
associated with poor BMD in subjects with
osteoarthritis of the knee and hip joint108,109. Several
investigators have assessed the possible relation
between presence and progression of osteoarthritis of
the knee joint and VDD108-110. Bischoff-Ferrari et al111
studied prevalence of knee osteoarthritis in elderly
subjects with mean age of 75 yr and reported
comparable prevalence of osteoarthritis in vitamin D
sufficient and deficient subjects (43.6 versus 50.4%).
Felson et al112 carried out a follow up study of 715
subjects with osteoarthritis recruited in Framingham and
277 adults with established osteoarthritis of knee joint
recruited in the ‘Boston osteoarthritis of knee study’.
Progression of the osteoarthritis was assessed by
sensitive measures such as radiographs and MRI of the
knee joint over a period of 9 yr.  On an average, one
fifth of subjects showed worsening of the osteoarthritis
as revealed by narrowing of the joint space and loss of
the cartilage on MRI. Besides, there was no significant
association between baseline 25(OH) D levels and
radiographic worsening. Thus, contrary to the popular
belief the results of the recent studies involving
sufficient number of subjects and statistical power did
not reveal association between VDD and osteoarthritis.
However, in most of the above studies mean serum
25(OH) D values at baseline were > 20 ng/ml; almost
double the mean value observed in Asian Indians4. In
view of high prevalence of osteoarthritis and potential
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benefit in Indians, there is a need to perform studies
assessing prevalence and worsening of osteoarthritis
with severe hypovitaminosis D in our country.
Conclusion
Overall results of various studies conducted to date
in urban and rural India indicate that widely prevalent
VDD is functionally relevant to skeletal health including
osteomalacia and rickets. There is a need to explore its
association with osteoporosis related fractures and
various other non skeletal disorders linked with VDD.
Considering the wide prevalence of VDD in rural areas
of India, that too in the southern Indian States with
almost perennial sunshine, it is unlikely that sunshine
exposure alone as a healthy life style measure would
result in vitamin D sufficiency in us. This is
predominantly due to skin pigmentation. In such a
scenario active intervention is required in the form of a
National policy for vitamin D food fortification
programme in our country.
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